Conceptus buys Ovion birth control patents
This article was originally published in The Gray Sheet
Executive Summary
Maker of the Essure non-incisional permanent birth control device buys Ovion female sterilization technology patents from American Medical Systems for $23.6 million on Oct. 5. The deal releases Conceptus from its royalty obligations under a 2003 agreement and increases the firm's ability to develop a next-generation version of Essure, according to the company. AMS had acquired the Ovion technology in 2005